SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $156,211 | -14.1% | 5,666 | -6.4% | 0.00% | – |
Q2 2023 | $181,892 | -19.9% | 6,051 | -3.5% | 0.00% | – |
Q1 2023 | $227,126 | +19.1% | 6,269 | +17.3% | 0.00% | – |
Q4 2022 | $190,692 | -3.7% | 5,346 | -8.8% | 0.00% | – |
Q3 2022 | $198,000 | +2.1% | 5,859 | -12.5% | 0.00% | – |
Q2 2022 | $194,000 | -37.2% | 6,694 | -30.1% | 0.00% | -100.0% |
Q1 2022 | $309,000 | -16.3% | 9,573 | -24.3% | 0.00% | 0.0% |
Q4 2021 | $369,000 | +7.3% | 12,650 | -2.1% | 0.00% | 0.0% |
Q3 2021 | $344,000 | -18.3% | 12,916 | -5.6% | 0.00% | 0.0% |
Q2 2021 | $421,000 | +23.1% | 13,685 | +4.7% | 0.00% | 0.0% |
Q1 2021 | $342,000 | +20.4% | 13,066 | +15.8% | 0.00% | 0.0% |
Q4 2020 | $284,000 | +5.6% | 11,282 | -12.9% | 0.00% | 0.0% |
Q3 2020 | $269,000 | -32.6% | 12,946 | -22.8% | 0.00% | 0.0% |
Q2 2020 | $399,000 | +9.3% | 16,768 | -17.3% | 0.00% | 0.0% |
Q1 2020 | $365,000 | -26.0% | 20,269 | -2.5% | 0.00% | 0.0% |
Q4 2019 | $493,000 | -32.7% | 20,796 | -21.8% | 0.00% | -50.0% |
Q3 2019 | $732,000 | -31.4% | 26,598 | -17.5% | 0.00% | -33.3% |
Q2 2019 | $1,067,000 | -24.4% | 32,236 | -19.9% | 0.00% | -25.0% |
Q1 2019 | $1,411,000 | +18.1% | 40,254 | +11.9% | 0.00% | 0.0% |
Q4 2018 | $1,195,000 | -17.4% | 35,986 | +25.3% | 0.00% | 0.0% |
Q3 2018 | $1,446,000 | +1.3% | 28,719 | +20.3% | 0.00% | 0.0% |
Q2 2018 | $1,428,000 | +25.7% | 23,873 | -3.7% | 0.00% | +33.3% |
Q1 2018 | $1,136,000 | +2.9% | 24,790 | -10.5% | 0.00% | 0.0% |
Q4 2017 | $1,104,000 | -14.0% | 27,692 | -13.7% | 0.00% | -25.0% |
Q3 2017 | $1,284,000 | -21.7% | 32,083 | -15.6% | 0.00% | -20.0% |
Q2 2017 | $1,639,000 | +27.6% | 38,022 | -7.2% | 0.01% | +25.0% |
Q1 2017 | $1,284,000 | +1.5% | 40,990 | -18.2% | 0.00% | -20.0% |
Q4 2016 | $1,265,000 | -6.3% | 50,098 | -8.1% | 0.01% | 0.0% |
Q3 2016 | $1,350,000 | +10.8% | 54,508 | -8.9% | 0.01% | 0.0% |
Q2 2016 | $1,218,000 | +36.4% | 59,804 | +2.1% | 0.01% | +25.0% |
Q1 2016 | $893,000 | -0.1% | 58,599 | -12.0% | 0.00% | 0.0% |
Q4 2015 | $894,000 | +98.2% | 66,584 | +106.9% | 0.00% | +100.0% |
Q3 2015 | $451,000 | +615.9% | 32,179 | +760.9% | 0.00% | – |
Q2 2015 | $63,000 | -55.6% | 3,738 | -68.2% | 0.00% | -100.0% |
Q1 2015 | $142,000 | +44.9% | 11,765 | 0.0% | 0.00% | – |
Q4 2014 | $98,000 | +2.1% | 11,765 | +6.5% | 0.00% | – |
Q3 2014 | $96,000 | -20.7% | 11,050 | 0.0% | 0.00% | – |
Q2 2014 | $121,000 | +22.2% | 11,050 | 0.0% | 0.00% | – |
Q1 2014 | $99,000 | +19.3% | 11,050 | 0.0% | 0.00% | – |
Q4 2013 | $83,000 | +2.5% | 11,050 | 0.0% | 0.00% | – |
Q3 2013 | $81,000 | – | 11,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |